Suma Krishnan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Suma Krishnan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Suma Krishnan. Suma Krishnan is Vice President, Product Dev. in NEW RIVER PHARMACEUTICALS INC ($NRPH) and VP, Product Development in NEW RIVER PHARMACEUTICALS INC ($NRPH) and SVP--Product Development in INTREXON CORP ($XON) and Chief Operating Officer in Krystal Biotech, Inc. ($KRYS).
Latest Insider Trading Transactions of Suma Krishnan
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, KRYS, NRPH, XON
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2021 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Option Exercise | A | 78.89 | 42,600 | 3,360,714 | 42,600 | |
Mar 02 2021 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Grant | A | 0.00 | 28,400 | 0 | 1,864,464 | 1.8 M to 1.9 M (+1.55 %) |
Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 47.29 | 1,126 | 53,248 | 1,836,064 | 1.8 M to 1.8 M (-0.06 %) |
Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 46.63 | 7,437 | 346,813 | 1,837,190 | 1.8 M to 1.8 M (-0.40 %) |
Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 46.09 | 10,594 | 488,297 | 1,844,627 | 1.9 M to 1.8 M (-0.57 %) |
Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 46.85 | 5,142 | 240,896 | 1,855,221 | 1.9 M to 1.9 M (-0.28 %) |
Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 46.24 | 9,749 | 450,821 | 1,860,363 | 1.9 M to 1.9 M (-0.52 %) |
Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 47.15 | 1,517 | 71,523 | 1,870,112 | 1.9 M to 1.9 M (-0.08 %) |
Sep 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 46.21 | 14,435 | 667,031 | 1,871,629 | 1.9 M to 1.9 M (-0.77 %) |
Jun 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 45.07 | 11,719 | 528,182 | 1,886,064 | 1.9 M to 1.9 M (-0.62 %) |
Jun 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 44.56 | 11,311 | 504,058 | 1,897,783 | 1.9 M to 1.9 M (-0.59 %) |
Jun 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 43.21 | 10,740 | 464,070 | 1,909,094 | 1.9 M to 1.9 M (-0.56 %) |
Jun 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 42.24 | 8,652 | 365,427 | 1,919,834 | 1.9 M to 1.9 M (-0.45 %) |
Jun 17 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 41.31 | 7,578 | 313,038 | 1,928,486 | 1.9 M to 1.9 M (-0.39 %) |
Mar 18 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 40.20 | 659 | 26,493 | 1,936,064 | 1.9 M to 1.9 M (-0.03 %) |
Mar 18 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 42.03 | 4 | 168 | 1,936,723 | 1.9 M to 1.9 M (0.00 %) |
Mar 18 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 41.27 | 1,396 | 57,607 | 1,936,727 | 1.9 M to 1.9 M (-0.07 %) |
Mar 18 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 40.49 | 10,780 | 436,429 | 1,938,123 | 1.9 M to 1.9 M (-0.55 %) |
Mar 18 2020 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 40.14 | 2,559 | 102,714 | 1,948,903 | 2 M to 1.9 M (-0.13 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 63.31 | 239 | 15,132 | 1,951,462 | 2 M to 2 M (-0.01 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 62.65 | 5,756 | 360,592 | 1,951,701 | 2 M to 2 M (-0.29 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 61.28 | 900 | 55,153 | 1,957,457 | 2 M to 2 M (-0.05 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 60.19 | 1,017 | 61,215 | 1,958,357 | 2 M to 2 M (-0.05 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 59.49 | 1,200 | 71,387 | 1,959,374 | 2 M to 2 M (-0.06 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 63.35 | 279 | 17,674 | 1,960,574 | 2 M to 2 M (-0.01 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 62.79 | 1,834 | 115,158 | 1,960,853 | 2 M to 2 M (-0.09 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 61.72 | 891 | 54,994 | 1,962,687 | 2 M to 2 M (-0.05 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 60.46 | 8,799 | 531,996 | 1,963,578 | 2 M to 2 M (-0.45 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 59.87 | 8,138 | 487,203 | 1,972,377 | 2 M to 2 M (-0.41 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 65.60 | 322 | 21,125 | 1,980,515 | 2 M to 2 M (-0.02 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 64.28 | 5,856 | 376,413 | 1,980,837 | 2 M to 2 M (-0.29 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 63.62 | 7,396 | 470,559 | 1,986,693 | 2 M to 2 M (-0.37 %) |
Dec 18 2019 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Sell | S | 62.84 | 7,373 | 463,352 | 1,994,089 | 2 M to 2 M (-0.37 %) |
Oct 22 2018 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Buy | P | 20.00 | 25,000 | 500,000 | 2,001,462 | 2 M to 2 M (+1.26 %) |
Jun 07 2018 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Buy | P | 12.45 | 1,018 | 12,674 | 1,976,462 | 2 M to 2 M (+0.05 %) |
Jun 07 2018 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Buy | P | 11.15 | 13,116 | 146,178 | 1,975,444 | 2 M to 2 M (+0.67 %) |
Jun 07 2018 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Buy | P | 10.75 | 10,866 | 116,757 | 1,962,328 | 2 M to 2 M (+0.56 %) |
Jun 05 2018 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Buy | J | 0.00 | 16,213 | 0 | 1,951,462 | 1.9 M to 2 M (+0.84 %) |
Sep 25 2017 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Option Exercise | C | 0.00 | 112,162 | 0 | 0 | |
Sep 25 2017 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Buy | C | 0.00 | 112,162 | 0 | 112,162 | 0 to 112.2 K |
Sep 25 2017 | KRYS | Krystal Biotech, I ... | Krishnan Suma | Chief Operating Off ... | Buy | P | 10.00 | 100,000 | 1,000,000 | 1,935,249 | 1.8 M to 1.9 M (+5.45 %) |
Feb 01 2016 | XON | INTREXON CORP | Krishnan Suma | SVP--Product Develo ... | Option Exercise | M | 6.88 | 14,657 | 100,840 | 30,591 | |
Feb 01 2016 | XON | INTREXON CORP | Krishnan Suma | SVP--Product Develo ... | Option Exercise | M | 6.88 | 14,657 | 100,840 | 533,362 | |
Feb 01 2016 | XON | INTREXON CORP | Krishnan Suma | SVP--Product Develo ... | Buy | M | 6.88 | 14,657 | 100,840 | 56,657 | 42 K to 56.7 K (+34.90 %) |
Feb 01 2016 | XON | INTREXON CORP | Krishnan Suma | SVP--Product Develo ... | Buy | M | 6.88 | 14,657 | 100,840 | 56,657 | 42 K to 56.7 K (+34.90 %) |
Dec 04 2015 | XON | INTREXON CORP | Krishnan Suma | SVP--Product Develo ... | Sell | S | 30.12 | 900 | 27,111 | 42,000 | 42.9 K to 42 K (-2.10 %) |
Dec 04 2015 | XON | INTREXON CORP | Krishnan Suma | SVP--Product Develo ... | Sell | S | 35.91 | 20,000 | 718,260 | 42,900 | 62.9 K to 42.9 K (-31.80 %) |
May 20 2015 | XON | INTREXON CORP | Krishnan Suma | SVP--Product Develo ... | Option Exercise | M | 7.12 | 42,000 | 299,040 | 529,428 | |
May 20 2015 | XON | INTREXON CORP | Krishnan Suma | SVP--Product Develo ... | Option Exercise | M | 7.12 | 42,000 | 299,040 | 43,714 | |
May 20 2015 | XON | INTREXON CORP | Krishnan Suma | SVP--Product Develo ... | Buy | M | 7.12 | 42,000 | 299,040 | 42,000 | 0 to 42 K |
May 20 2015 | XON | INTREXON CORP | Krishnan Suma | SVP--Product Develo ... | Buy | M | 7.12 | 42,000 | 299,040 | 62,900 | 20.9 K to 62.9 K (+200.96 %) |
Jan 31 2007 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | A | 56.39 | 178,920 | 10,089,299 | 178,920 | |
Jan 31 2007 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | A | 56.39 | 119,280 | 6,726,199 | 119,280 | |
Nov 13 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 4.00 | 25,667 | 102,668 | 45,000 | |
Nov 13 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 1.25 | 33,333 | 41,666 | 0 | |
Nov 13 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 48.23 | 35,217 | 1,698,505 | 0 | 35.2 K to 0 (-100.00 %) |
Nov 13 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 49.01 | 54,783 | 2,684,948 | 35,217 | 90 K to 35.2 K (-60.87 %) |
Nov 13 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 4.00 | 25,667 | 102,668 | 90,000 | 64.3 K to 90 K (+39.90 %) |
Nov 13 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 1.25 | 33,333 | 41,666 | 64,333 | 31 K to 64.3 K (+107.53 %) |
Oct 26 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 12.00 | 63,900 | 766,800 | 191,700 | |
Oct 26 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | D | 48.65 | 63,900 | 3,108,735 | 31,000 | 94.9 K to 31 K (-67.33 %) |
Oct 26 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 12.00 | 63,900 | 766,800 | 94,900 | 31 K to 94.9 K (+206.13 %) |
May 19 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 4.00 | 29,333 | 117,332 | 70,667 | |
May 19 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 1.25 | 667 | 834 | 33,333 | |
May 19 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 29.21 | 30,000 | 876,204 | 31,000 | 61 K to 31 K (-49.18 %) |
May 19 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 4.00 | 29,333 | 117,332 | 61,000 | 31.7 K to 61 K (+92.63 %) |
May 19 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 1.25 | 667 | 834 | 31,667 | 31 K to 31.7 K (+2.15 %) |
Mar 22 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 1.25 | 30,000 | 37,500 | 34,000 | |
Mar 22 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 30.86 | 30,000 | 925,737 | 31,000 | 61 K to 31 K (-49.18 %) |
Mar 22 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 1.25 | 30,000 | 37,500 | 61,000 | 31 K to 61 K (+96.77 %) |
Feb 15 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 4.00 | 20,000 | 80,000 | 105,000 | |
Feb 15 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 1.25 | 62,536 | 78,170 | 0 | |
Feb 15 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 1.25 | 17,464 | 21,830 | 62,536 | |
Feb 15 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 30.00 | 20,000 | 600,000 | 1,000 | 21 K to 1,000 (-95.24 %) |
Feb 15 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 4.00 | 20,000 | 80,000 | 21,000 | 1,000 to 21 K (+2,000.00 %) |
Feb 15 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 30.00 | 62,536 | 1,876,080 | 1,000 | 63.5 K to 1,000 (-98.43 %) |
Feb 15 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 1.25 | 62,536 | 78,170 | 63,636 | 1.1 K to 63.6 K (+5,685.09 %) |
Feb 15 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 30.12 | 17,464 | 525,958 | 1,000 | 18.5 K to 1,000 (-94.58 %) |
Feb 15 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 1.25 | 17,464 | 21,830 | 18,464 | 1,000 to 18.5 K (+1,746.40 %) |
Jan 23 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | VP, Product Develop ... | Option Exercise | A | 32.71 | 191,700 | 6,270,507 | 191,700 | |
Jan 23 2006 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | VP, Product Develop ... | Option Exercise | A | 32.71 | 127,800 | 4,180,338 | 127,800 | |
Nov 22 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 2.50 | 2,000 | 5,000 | 32,000 | |
Nov 22 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 51.34 | 5,000 | 256,723 | 15,500 | 20.5 K to 15.5 K (-24.39 %) |
Nov 22 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 2.50 | 2,000 | 5,000 | 20,500 | 18.5 K to 20.5 K (+10.81 %) |
Sep 13 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 2.50 | 53,160 | 132,900 | 40,813 | |
Sep 13 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 41.23 | 53,160 | 2,191,787 | 500 | 53.7 K to 500 (-99.07 %) |
Sep 13 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 2.50 | 53,160 | 132,900 | 53,660 | 500 to 53.7 K (+10,632.00 %) |
Sep 06 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 2.50 | 3,419 | 8,548 | 53,973 | |
Sep 06 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 2.50 | 1,628 | 4,070 | 57,392 | |
Sep 06 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 2.50 | 1,793 | 4,483 | 59,020 | |
Sep 06 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 42.02 | 3,419 | 143,666 | 500 | 3.9 K to 500 (-87.24 %) |
Sep 06 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 2.50 | 3,419 | 8,548 | 3,919 | 500 to 3.9 K (+683.80 %) |
Sep 06 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 41.01 | 1,628 | 66,764 | 500 | 2.1 K to 500 (-76.50 %) |
Sep 06 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 2.50 | 16,628 | 41,570 | 2,128 | -14,500 to 2.1 K (-114.68 %) |
Sep 06 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 41.87 | 1,793 | 75,073 | 500 | 2.3 K to 500 (-78.19 %) |
Sep 06 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 2.50 | 1,793 | 4,483 | 2,293 | 500 to 2.3 K (+358.60 %) |
Aug 23 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 36.95 | 5,000 | 184,750 | 18,500 | 23.5 K to 18.5 K (-21.28 %) |
Jun 17 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 2.50 | 11,000 | 27,500 | 100,813 | |
Jun 17 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Sell | S | 30.00 | 11,000 | 330,000 | 8,000 | 19 K to 8 K (-57.89 %) |
Jun 17 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 2.50 | 11,000 | 27,500 | 19,000 | 8 K to 19 K (+137.50 %) |
Mar 31 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | A | 24.00 | 191,700 | 4,600,800 | 191,700 | |
Mar 31 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | A | 24.00 | 127,800 | 3,067,200 | 127,800 | |
Feb 28 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | M | 2.50 | 16,000 | 40,000 | 34,000 | |
Feb 28 2005 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | M | 2.50 | 16,000 | 40,000 | 23,500 | 7.5 K to 23.5 K (+213.33 %) |
Aug 11 2004 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | A | 8.00 | 100,000 | 800,000 | 100,000 | |
Aug 11 2004 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Option Exercise | A | 8.00 | 50,000 | 400,000 | 50,000 | |
Aug 11 2004 | NRPH | NEW RIVER PHARMACE ... | Krishnan Suma | Vice President, Pro ... | Buy | P | 8.00 | 500 | 4,000 | 500 | 0 to 500 |
Page: 1